Expression of Concern: Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice (PLoS ONE (2013) 8:4 (e60863) DOI: 10.1371/journal.pone.0060863);Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Moriguchi, Shigeki ^a   Shinoda, Yasuharu ^a   Yamamoto, Yui ^a   Sasaki, Yuzuru ^a   Miyajima, Kosuke ^a   Tagashira, Hideaki ^a   Fukunaga, Kohji ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLUTAMATE RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; PRASTERONE; PROTEIN KINASE C; SERINE; SERINE 308; SERINE 473; SERINE 9; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AUTOPHOSPHORYLATION; COGNITION; DENTATE GYRUS; DEPRESSION; DOWNSTREAM PROCESSING; FORCED SWIMMING TEST; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLFACTORY BULBECTOMY;

EID: 84875999311     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0290363     Document Type: Erratum

References (70)

1. Corwin J, Serby M, Conrad P, Rotrosen J, (1985) Olfactory recognition deficit in Alzheimer's disease and Parkinsonian dementia. IRCS Med Sci 13: 260.
2. Koss E, (1986) Olfactory dysfunction in Alzheimer's disease. Dev Neuropsychol 2: 89-99.
3. Warner MD, Peabody CA, Flattery JJ, Tinklenberg JR, (1986) Olfactory deficits and Alzheimer's disease. Biol Psychiatry 2: 116-118.
4. Kovacs T, Cairns NJ, Lantos PL, (2001) Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stage. Neuroreport 12: 285-288.
5. Han F, Shioda N, Moriguchi S, Qin ZH, Fukunaga K, (2008) The vanadium (LV) compound rescues septo-hippocampal cholinergic neurons from neurodegeneration in olfactory bulbectomized mice. Neuroscience 151: 671-679.
6. Yamamoto T, Jin J, Watanabe S, (1997) Characteristics of memory dysfunction in olfactory bulbectomized rats and the effects of cholinergic drugs. Behav Brain Res 83: 57-62.
7. Kelly JP, Wrynn AS, Leonard BE, (1997) The olfactory bulbectomized rat as a model of depression: An update. Pharmacol Ther 74: 299-316.
8. Cain DP, (1974) The role of the olfactory bulb in limbic mechanisms. Psychol Bull 81: 654-671.
9. Sieck MH, (1972) The role of the olfactory system in avoidance learning and activity. Physiol Behav 8: 705-710.
10. Moriguchi S, Han F, Nakagawasai O, Tadano T, Fukunaga K, (2006) Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice. J Neurochem 97: 22-29.
11. Gould E, Tanapat P, Rydel T, Hastings N, (2000) Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry 48: 715-720.
12. Malberg JE, Duman RS, (2003) Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28: 1562-1571.
13. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809.
14. Shioda N, Yamamoto Y, Han F, Moriguchi S, Yamaguchi Y, et al. (2010) A novel cognitive enhancer, ASET1446/ST101, promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice. J Pharmacol Exp Ther 333: 43-50.
15. Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ, (1999) Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 2: 260-265.
16. Madson TM, Kristjansen PE, Blowig TG, Wortwein G, (2003) Arrested neuronal proliferation and impaired hippocampal function following fractionated brain irradiation in the adult rat. Neuroscience 119: 635-642.
17. Rola R, Raber J, Rizk A, Otsuka S, VandenBerg SR, et al. (2004) Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp Neurol 188: 316-330.
18. Baulieu EE, Robel P, (1998) Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteloids. Proc Natl Acad Sci USA 95: 4089-4091.
19. Orentreich N, Brind JL, Vogelman R, Andres H, Baldwin H, (1992) Long-term longitudinal measurement of plasma dehyroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75: 1002-1004.
20. Vermeulen A, (1995) Dehydroepiandrosterone sulfate and aging. Ann NY Acad Sci 774: 121-127.
21. Sunderland TS, Merril CR, Harrington MG, Lawlor MG, Molchan SE, et al. (1989) Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 2: 570.
22. Maurice T, (2001) Beneficial effect of the sigma (1) receptor agonist PRE-084 against the spatial learning deficits in aged rats. Eur J Pharmacol 431: 223-227.
23. Moriguchi S, Yamamoto Y, Ikuno T, Fukunaga K, (2011) Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice. J Neurochem 117: 879-891.
24. Bliss TV, Collingridge GL, (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39.
25. Fukunaga K, Stoppini L, Miyamoto E, Muller D, (1993) Long-term potentiation is associated with a increased activity of Ca2+/calmodulin-dependent protein kinase II. J Bio Chem 268: 7863-7867.
26. Kasahara J, Fukunaga K, Miyamoto E, (2001) Activation of calcium/calmodulin-dependent protein kinase IV in long term potentiation in the rat hippocampal CA1 region. J Biol Chem 276: 24044-24050.
27. Lledo PM, Hjelmstad GO, Mukherji S, Soderling TR, Malenka RC, et al. (1995) Calcium/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism. Proc Natl Acad Sci USA 92: 11175-11179.
28. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR, (1997) Regulatory phosphorylation of AMPA-type glutamate receptor by CaMKII during long-term potentiation. Science 276: 2042-2045.
29. Lisman J, Schulman H, Cline H, (2002) The molecular basis of CaMKII function in synaptic and behavioral memory. Nature Rev Neurosci 3: 175-190.
30. Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, et al. (1999) Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Sceince 284: 1811-1816.
31. Poncer JC, Esteban JA, Malinow R, (2002) Multiple mechanisms for the potentiation of AMPA receptor-mediated transmission by alpha-Ca2+/calmodulin-dependent protein kinase II. J Neurosci 22: 4406-4411.
32. Song I, Huganir RL, (2002) Regulation of AMPA receptors during synaptic plasticity. Trends Neurosci 25: 578-588.
33. Miyano O, Kameshita I, Fijisawa H, (1992) Purification and characterization of a brain-specific multifunctional calmodulin-dependent protein kinase from rat cerebellum. J Biol Chem 267: 1198-1203.
34. Jensen KF, Ohmstede CA, Fisher RS, Sahyoun N, (1991) Acquisition and loss of a neuronal Ca2+/calmodulin-dependent protein kinase during neuronal differentiation. Proc Natl Acad Sci USA 88: 4050-4053.
35. Steru L, Chermat R, Thierry B, Simon P, (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85: 367-370.
36. Porsolt RD, Le Pichon M, Jalfre M, (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266: 730-732.
37. Moriguchi S, Shioda N, Han F, Narahashi T, Fukunaga K, (2008) CaM kinase II and protein kinase C activations mediate enhancement of long-term potentiation by nefiracetam in the rat hippocampal CA1 region. J Neurochem 106: 1092-1103.
38. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
39. Fukunaga K, Horikawa K, Shibata S, Takeuchi Y, Miyamoto E, (2002) Ca2+/calmodulin-dependent protein kinase II-dependent long-term potentiation in the rat suprachiasmatic nucleus and its inhibition by melatonin. J Neurosci Res 70: 799-807.
40. Fukunaga K, Muller D, Miyamoto E, (1995) Increased phosphorylation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in the induction of long term potentiation. J Biol Chem 270: 6119-6124.
41. Derkach V, Barria A, Soderling T, (1999) Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci USA 96: 3269-3274.
42. Yamagata Y, (2003) New aspects of neurotransmitter release and exocytosis: dynamic and differential regulation of synapsin I phosphorylation by acute neuronal excitation in vivo. J Pharmacol Sci 93: 22-29.
43. Li BS, Ma W, Zhang L, Barker JL, Stenger DA, et al. (2001) Activation of phosphatidylinositol 3-kinase (PI-3K) and extracellular regulated signal kinase (Erk1/2) is involved in muscarinic receptor-mediated DNA synthesis in neural progenitor cells. J Neurosci 21: 1569-1579.
44. Sharma M, Chuang WW, Sun Z, (2002) Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation. J Biol Chem 277: 30935-30941.
45. Ma T, Tzavaras N, Tsokas P, Landau EM, Blitzer RD, (2011) Synaptic stimulation of mTOR is mediated by Wnt signaling and regulation of glycogen synthetase kinase-3. J Neurosci 31: 17537-17546.
46. Tian HP, Huang BS, Zhao J, Hu ZH, Guo J, et al. (2009) Non-receptor tyrosine kinase Src is required for ischemia-stimulated neuronal cell proliferation via Raf/ERK/CREB activation in the dentate gyrus. BMC Neuroscience 10: 139.
47. Hellewell SB, Bowen WD, (1990) A σ-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+) benzomorphans and lower molecular weight suggest a different σ receptor form from that of guinea pig brain. Brain Res 527: 244-253.
48. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, et al. (1996) Purification, molecular cloning, and expression of the mammalian σ1 binding site. Proc Natl Acad Sci USA 93: 8072-8077.
49. Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, et al. (1994) Rat liver and kidney contain high densities of sigma1 and sigma2 receptors: characterazation by ligand and photoaffinity labeling. Eur J Pharmacol 268: 9-18.
50. Pal A, Hajipour AR, Fontanilla D, Ramachandran S, Chu UB, et al. (2007) Identification of regions of the σ-1 receptor ligand binding site using a novel photoprobe. Mol Pharmacol 72: 921-933.
51. Hayashi T, Su TP, (2004) Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc Natl Acad Sci USA 101: 14949-14954.
52. Palacios G, Muro A, Vela JM, Molina-Holgado E, Guitart X, et al. (2003) Immnohistochemical localization of the sigma1-receptor in oligodendrocytes in the rat central nervous system. Brain Res 961: 92-99.
53. Hayashi T, Maurice T, Su TP, (2000) Ca2+ signaling via sigma1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration. J Pharmacol Exp Ther 293: 788-798.
54. Hayashi T, Su TP, (2003) Intracellular synamics of sigma-1 receptor (sigma (1) binding sites) in NG108-15 cells. J Pharmacol Exp Ther 306: 726-733.
55. Hayashi T, Su TP, (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell 131: 596-610.
56. Su TP, London ED, Jaffe JH, (1998) Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 240: 219-221.
57. Sabino V, Cottone P, Parylak SL, Steardo L, Zorrilla EP, (2009) Sigma-1 receptor knockout mice display a depressive-like phenotype. Bevavioral Brain Res 198: 472-476.
58. Hozumi S, Nakagawasai O, Tan-No K, Niijima F, Yamadera F, et al. (2003) Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav Brain Res 138: 9-15.
59. Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E, et al. (1999) Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 142: 193-199.
60. Frotscher M, Leranth C, (1985) Cholinergic innervation of the rat hippocampus as revealed by choline acethyltransferase immunocytochemistry: a combined light and electron microscopic study. J Comp Neurol 239: 237-246.
61. Kaneko N, Okano H, Sawamoto K, (2006) Role of the cholinergic system in regulating survival of newborn neurons in the adult mouse dentate gyrus and olfactory bulb. Genes Cells 11: 1145-1159.
62. Cooper-Kuhn M, Winkler J, Kuhn HG, (2004) Decreased neurogenesis after cholinergic forebrain lesion in the adult rat. J Neurosci Res 77: 155-165.
63. Matsuno K, Matsunaga K, Senda T, Mita S, (1993) Increase in extracellular acethylcholine level by sigma ligands in rat frontal cortex. J Pharmacol Exp Ther 265: 851-859.
64. Junian JL, Roman FJ, Brunelle G, Pascaud X, (1991) JO-1784, a novel sigma ligands, potentiates [3H] acethylcholine release from rat hippocampal slices. Eur J Pharmacol 200: 343-345.
65. Shioda N, Ishikawa K, Tagashira H, Ishizuka T, Yawo H, et al. (2012) Expression of a truncated form of the endoplasmic reticulum chaperone protein, σ1 receptor, promotes mitochondrial energy depletion and apoptosis. J Biol Chem 287: 23318-23331.
66. Irwin RP, Lin SZ, Rogawski MA, Purdy RH, Paul SM, (1994) Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca2+ response: structure-activity studies. J Pharmacol Exp Ther 271: 677-682.
67. Collingridge GL, Issac JT, Wang YT, (2004) Receptor trafficking and synaptic plasticity. Nat Rev Neurosci 5: 952-962.
68. Martina M, Turcotte MEB, Halman S, Bergeron R, (2007) The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 578: 143-157.
69. Chatterjee S, Browning EA, Hong N, DeBolt K, Sorokina EM, et al. (2012) Membrane depolarization is the trigger for PI3K/Akt activation and leads to the generation of ROS. Am J physiol Heart Circ Physiol 302: H105-H114.
70. Huddleston AT, Tang W, Kakeshima H, Hamilton SL, Klann E, (2007) Superoxide-induced potentiation in the hippocampus requires activation of ryanodine receptor type3 and ERK. J Neurophysiol 99: 1565-1571.